ArticleLeukemia2009

The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis.

Q-L Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.